Notable Downgrades: Diplomat Pharmacy (DPLO), Gilead Sciences (GILD), Dunkin’ Brands Group (DNKN), Progress Software (PRGS)

Analysts at Morgan Stanley (MS) downgraded Diplomat Pharmacy, Inc. (DPLO) from ‘Overweight’ to ‘Equal-Weight’ in a research report issued to clients on Friday. On valuation measures, Diplomat Pharmacy Inc. stock it’s trading at a forward P/E multiple of 31.68x, and at a multiple of 150.38x this year’s estimated earnings. The t-12-month revenue at Diplomat Pharmacy […] View the full post at: Notable Downgrades: Diplomat Pharmacy (DPLO), Gilead Sciences (GILD), Dunkin’ Brands Group (DNKN), Progress Software (PRGS) Related posts: Gilead Sciences Announces Large Buyback Gilead Sciences is in Great Health China, U.S. agree to respect “core interests”: diplomat